Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “therapy”

782 pharma patents match "therapy" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 782
Index total 30,257
Page 18 / 33

Quick answer

This filtered view shows 782 pharmaceutical patents matching "therapy" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

782 results for “therapy” · 30,257 patents in full index Clear search

  1. US 10322146

    Methods of conditioning patients for T cell therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  2. US 10322095

    Endoxifen for local transdermal therapy to the breast

    Northwestern University · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted

  3. US 10314924

    RPGR gene therapy for retinitis pigmentosa

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  4. US 10316050

    PT (IV) complexes containing 4,4′-disubstituted-2,2′-bipyridyl and their use in cancer therapy

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  5. US 10301365

    Met e 1 tropomyosin variants for use in allergen-specific immunotherapy

    The Regents of the University of California · Granted May 28, 2019 · Expires May 23, 2039

    granted

  6. US 10300074

    Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapy

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted May 28, 2019 · Expires May 23, 2039

    granted

  7. US 10293056

    Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases

    The Board of Regents of the University of Texas System · Granted May 21, 2019 · Expires May 16, 2039

    granted

  8. US 10272099

    Tumor-selective combination therapy

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  9. US 10272113

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  10. US 10265397

    Formulation for photodynamic therapy

    SANOCHEMIA PHARMAZEUTIKA AG · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  11. US 10265412

    Enzyme replacement therapy for treating lysosomal storage diseases

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  12. US 10258678

    Indoleamine 2,3-dioxygenase based immunotherapy

    IO Biotech ApS · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  13. US 10231958

    Methods and compositions for enhancing chemotherapy

    The Board of Regents of the University of Texas System · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  14. US 2019076525

    THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

    GANYMED PHARMACEUTICALS GMBH [DE] · Granted Mar 14, 2019 · Expires Mar 9, 2039

    granted

  15. US 10221244

    Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer

    Five Prime Therapeutics, Inc. · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  16. US 10221455

    Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy

    BIOVERATIV THERAPEUTICS INC. · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  17. US 10195297

    Iron garnet nanoparticles for cancer radiotherapy and chemotherapy

    The Board of Regents of the University of Texas System · Granted Feb 5, 2019 · Expires Jan 31, 2039

    granted

  18. US 10188751

    Papillomavirus pseudoviruses for detection and therapy of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 29, 2019 · Expires Jan 24, 2039

    granted

  19. US 10179112

    Viral vector nanocapsule for targeting gene therapy and its preparation

    The Regents of the University of California · Granted Jan 15, 2019 · Expires Jan 10, 2039

    granted

  20. US 10172836

    Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation supression therapy

    PTC THERAPEUTICS, INC. · Granted Jan 8, 2019 · Expires Jan 3, 2039

    granted

  21. US 10166277

    Vault immunotherapy

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  22. US 10166255

    Intracellular genomic transplant and methods of therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  23. US 10166257

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

  24. US 10167337

    Combination immunotherapy for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jan 1, 2019 · Expires Dec 27, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.